Received Dec 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | — |
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
Headache; Chills; body aches; Inappropriate schedule of vaccine administered/not able to get the second shot; Sick; This non-serious case was reported by a consumer via call center representative and described the occurrence of headache in a female patient who received Herpes zoster (Shingrix) for prophylaxis. Co-suspect products included Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix and did not receive 2nd dose of Shingrix. On an unknown date, less than a year after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced headache (Verbatim: Headache), chills (Verbatim: Chills), general body pain (Verbatim: body aches), sickness (Verbatim: Sick) and incomplete course of vaccination (Verbatim: Inappropriate schedule of vaccine administered/not able to get the second shot). The outcome of the headache, chills and general body pain were unknown and the outcome of the sickness was resolved (duration 1 day) and the outcome of the incomplete course of vaccination was not applicable. It was unknown if the reporter considered the headache, chills, general body pain and sickness to be related to Shingrix. It was unknown if the company considered the headache, chills, general body pain and sickness to be related to Shingrix. Additional Information: GSK Receipt Date: 09-DEC-2025 The patient had the initial vaccination shot for shingles in 2019. The patient was not able to get the second shot. The patient was sick for a day after that first shot and experienced headache chills, body-aches in 2019 and was wondering if she should go ahead and re-restart the two-shot regimen. The batch number was not provided and we and unable to contact the reporter.